3-Phenylpropanoylfentanyl

3-Phenylpropanoylfentanyl

Legal status
Legal status	Illegal in Sweden, Finland and Lithuania
Identifiers
IUPAC name N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-3-phenylpropanamide
CAS Number	79279-02-0
Chemical and physical data
Formula	C28H32N2O
Molar mass	412.565
3D model (JSmol)	Interactive image
SMILES c2ccccc2CCN1CCC(CC1)N(c3ccccc3)C(=O)CCc4ccccc4

3-Phenylpropanoylfentanyl (β'-Phenylfentanyl) is an opioid analgesic that is an analog of fentanyl, which was invented in 1981, and has been sold as a designer drug, first identified in March 2017 in Sweden.

Side effects of fentanyl analogs are similar to those of fentanyl itself, which include itching, nausea and potentially serious respiratory depression, which can be life-threatening. Fentanyl analogs have killed hundreds of people throughout Europe and the former Soviet republics since the most recent resurgence in use began in Estonia in the early 2000s, and novel derivatives continue to appear. A new wave of fentanyl analogues and associated deaths began in around 2014 in the USA, and have continued to grow in prevalence; especially since 2016 these drugs have been responsible for hundreds of overdose deaths every week.

3-Phenylpropanoylfentanyl was banned in Finland in September 2017, and in Sweden in October 2017. It was also banned in Lithuania in 2017.